Tadalafil Tablet, Film Coated
FDA Label NDC 70771-1477

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Tadalafil (NDC 70771-1477). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1475-3 in bottle of 30 tablets

Tadalafil Tablets USP, 2.5 mg

Rx Only

30 tablets

2.5 mg Label (89266030 A1a1 4825 B9f0 9400886b6282 01)

2.5 mg Label (89266030 A1a1 4825 B9f0 9400886b6282 01)

NDC 70771-1476-3 in bottle of 30 tablets

Tadalafil Tablets USP, 5 mg

Rx Only

30 tablets

5 mg (89266030 A1a1 4825 B9f0 9400886b6282 02)

5 mg (89266030 A1a1 4825 B9f0 9400886b6282 02)

NDC 70771-1477-3 in bottle of 30 tablets

Tadalafil Tablets USP, 10 mg

Rx Only

30 tablets

10 mg (89266030 A1a1 4825 B9f0 9400886b6282 03)

10 mg (89266030 A1a1 4825 B9f0 9400886b6282 03)

NDC 70771-1478-3 in bottle of 30 tablets

Tadalafil Tablets USP, 20 mg

Rx Only

30 tablets

20 mg (89266030 A1a1 4825 B9f0 9400886b6282 04)

20 mg (89266030 A1a1 4825 B9f0 9400886b6282 04)

* Please review the disclaimer below.